Anti‐thymocyte globulin‐mediated immunosenescent alterations of T cells in kidney transplant patients

Anti‐thymocyte globulin‐mediated immunosenescent alterations of T cells in kidney transplant patients

Abstract Objectives Kidney transplant (KT) is the most effective treatment for end‐stage renal disease. The immunosuppressant anti‐thymocyte globulin (ATG) has been applied for induction therapy to reduce the risk of acute transplant rejection for patients at high immunological risk. Despite its put...

Full description

Bibliographic Details
Main Authors: Ga Hye Lee, Jee Youn Lee, Jiyeon Jang, Yeon Jun Kang, Seung Ah Choi, Hyeon Chang Kim, Sungha Park, Myoung Soo Kim, Won‐Woo Lee
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Clinical & Translational Immunology
Subjects:
ATG
CD28‐ T cells
CMV
immunosenescence
kidney transplantation
Online Access:https://doi.org/10.1002/cti2.1431

Similar Items

Similar Items